Sirdupla: new LABA/corticosteroid inhaler

2 June 2015

Sirdupla (salmeterol/fluticasone) has been launched for use in adults with asthma where a long-acting ß2-agonist and inhaled corticosteroid is appropriate.

Sirdupla (salmeterol/fluticasone) is a bioequivalent alternative to Seretide Evohaler.
Sirdupla (salmeterol/fluticasone) is a bioequivalent alternative to Seretide Evohaler.

The metered-dose inhaler is available in two strengths:

  • 25/125 (salmeterol 25 microgram, fluticasone propionate 125 microgram)
  • 25/250 (salmeterol 25 microgram, fluticasone propionate 250 microgram)

Further information
View Sirdupla drug record 
Summary of Product Characteristics
Manufacturer: Mylan

Sirdupla can be used in patients over 18 years of age not adequately controlled with inhaled corticosteroids and an 'as needed' inhaled short-acting β2-agonist, and in those already adequately controlled on both an inhaled corticosteroid and a long-acting β2-agonist.

The efficacy and safety of salmeterol and fluticasone for the treatment of asthma are well established.

Prescribers should note that only the AeroChamber Plus spacer device should be used with Sirdupla. 

Want news like this straight to your inbox?
Sign up for our bulletins

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register
Already registered?
Sign in

The most up-to-date drug information at your fingertips.

  • Get the prescribing support you need.
  • Register today for full access to the MIMS database, plus tables and guideline summaries, new and deleted products and consultation tools.
Register Now
Already Registered?

Forgotten password?

More from MIMS

A man with his sleeves rolled up sits in a bare room heating heroin in a spoon over a lighter flame.

New implant treats opioid dependence for 6 months

Patients with opioid dependence can now be given a...

Drug shortages - live tracker

Use our constantly updated shortages tracker to check...

A woman wearing a white vest as a blue-gloved hand of a healthcare professional are seen injecting a vaccine.

'Nocebo' effect may cause two-thirds of COVID-19 vaccine reactions, study suggests

Two-thirds of adverse reactions reported with the COVID-19...

An elderly woman with one arm in a plaster cast sits resting both hands on her walker

Doctors urge NICE to reverse decision on new osteoporosis drug

More than NHS 100 clinicians have called on NICE to...